Abstract
Approximately 50 % of HIV-1 seropositive individuals develop HIV-1 associated neurocognitive disorders (HAND), which commonly include alterations in executive functions, such as inhibition, set shifting, and complex problem solving. Executive function deficits in HIV-1 are fairly well characterized, however, relatively few studies have explored the elemental dimensions of neurocognitive impairment in HIV-1. Deficits in temporal processing, caused by HIV-1, may underlie the symptoms of impairment in higher level cognitive processes. Translational measures of temporal processing, including cross-modal prepulse inhibition (PPI), gap-prepulse inhibition (gap-PPI), and gap threshold detection, were studied in mature (ovariectomized) female HIV-1 transgenic (Tg) rats, which express 7 of the 9 HIV-1 genes constitutively throughout development. Cross-modal PPI revealed a relative insensitivity to the manipulation of interstimulus interval (ISI) in HIV-1 Tg animals in comparison to control animals, extending previously reported temporal processing deficits in HIV-1 Tg rats to a more advanced age, suggesting the permanence of temporal processing deficits. In gap-PPI, HIV-1 Tg animals exhibited a relative insensitivity to the manipulation of ISI in comparison to control animals. In gap-threshold detection, HIV-1 Tg animals displayed a profound differential sensitivity to the manipulation of gap duration. Presence of the HIV-1 transgene was diagnosed with 91.1 % accuracy using gap threshold detection measures. Understanding the generality and permanence of temporal processing deficits in the HIV-1 Tg rat is vital to modeling neurocognitive deficits observed in HAND and provides a key target for the development of a diagnostic screening tool.
Similar content being viewed by others
References
Adler LE, Pachtman E, Franks RD, Pecevich M, Waldo MC, Freedman R (1982) Neurophysiological evidence for a defect in neuronal mechanisms involved in sensory gating in schizophrenia. Biol Psychiatry 17:639–654
Alfahad TB, Nath A (2013) Update on HIV-1 associated neurocognitive disorders. Current Neurol Neurosci 13:387
Ances BM, Ellis RJ (2007) Dementia and neurocognitive disorders due to HIV-1 infection. Semin Neurol 27:86–92
Braff D, Stone C, Callaway E, Geyer M, Glick I, Bali L (1978) Prestimulus effects on human startle reflex in normal and schizophrenics. Psychophysiology 15:339–343
Castello E, Baroni N, Pallestrini E (1998) Neurotological and auditory brain stem response findings in human immunodeficiency virus-positive patients without neurologic manifestations. Ann Otol Rhinol Laryngol 107:1054–1060
Chan P, Brew BJ (2014) HIV associated neurocognitive disorders in the modern antiviral treatment era: prevalence, characteristics, biomarkers, and effects of treatment. Curr HIV/AIDS Rep 11:317–324
Chang L, Wang GJ, Volkow ND, Ernst T, Telang F, Logan J, Fowler JS (2008) Decreased brain dopamine transporters are related to cognitive deficits in HIV patients with or without cocaine abuse. NeuroImage 42:869–878
Chao LL, Lindgren JA, Flenniken DL, Weiner MW (2004) ERP evidence of impaired central nervous system function in virally suppressed HIV patients on antiretroviral therapy. Clin Neurophysiol 115:1583–1591
Curzon, P, Zhang, M, Radek, RJ, Fox, GB (2009) The behavioral assessment of sensorimotor processes in the mouse: acoustic startle, sensory gating, locomotor activity, rotarod, and beam walking. In: Buccafusco, J (ed) Methods of behavior analysis in neuroscience, 2 edn. Boca Raton, FL, Chapter 8
Dehmel S, Eisinger D, Shore SE (2012) Gap prepulse inhibition and auditory brainstem-evoked potentials as objective measures for tinnitus in guinea pigs. Front Syst Neurosci 6:1–15
Di Rocco A, Bottiglieri T, Dorfman D, Werner P, Morrison C, Simpson D (2000) Decreased homovanilic acid in cerebrospinal fluid correlates with impaired neuropsychologic function in HIV-1-infected patients. Clin Neuropharmacol 23:190–194
Fein G, Biggins CA, Mackay S (1995) Delayed latency of the event-related brain potential P3A component in HIV disease: progressive effects with increasing cognitive impairment. Arch Neurol-Chicago 52:1109–1118
Fendt M, Li L, Yeomans JS (2001) Brain stem circuits mediating prepulse inhibition of the startle reflex. Psychopharmacology 156:216–224
Fitting S, Booze RM, Mactutus CF (2006a) Neonatal hippocampal Tat injections: developmental effects on prepulse inhibition (PPI) of the auditory startle response. Int J Dev Neurosci 24:275–283
Fitting S, Booze RM, Mactutus CF (2006b) Neonatal intrahippocampal glycoprotein 120 injection: the role of dopaminergic alteration in prepulse inhibition in adult rats. J Pharmacol Exp Ther 318:1352–1358
Fitting S, Booze RM, Mactutus CF (2008) Neonatal intrahippocampal injection of the HIV-1 proteins gp12 and Tat: differential effects on behavior and the relationship to stereological hippocampal measures. Brain Res 1232:139–154
Fournier P, Hébert S (2013) Gap detection deficits in humans with tinnitus as assessed with the acoustic startle paradigm: does tinnitus fill in the gap? Hear Res 295:16–23
Geyer MA, Swerdlow NR (2001) Measurement of startle response, prepulse inhibition, and habituation. Curr Protoc Neurosci 8
Geyer MA, Krebs-Thomson K, Braff DL, Swerdlow NR (2001) Pharmacological studies of prepulse inhibition models of sensorimotor gating deficits in schizophrenia: a decade in review. Psychopharmacology 156:117–154
Gil R, Breux JP, Neu JP, Becq-Giraudon B (1992) Cognitive evoked potentials and HIV infection. Clin Neurophysiol 22:385–391
Grant I, Franklin DR, Deutsch R, Woods SP, Vaida F, Ellis RJ et al (2014) Asymptomatic HIV-associated neurocognitive impairment increases risk for symptomatic decline. Neurology 83:2055–2062
Greenhouse SW, Geisser S (1959) On methods in the analysis of profile data. Psychometrika 24:95–112
Heaton RK, Clifford DB, Franklin DR, Woods SP, Ake C, Vaida F et al (2010) HIV-associated neurocognitive disorders persist in the era of potent antiretroviral therapy CHARTER study. Neurology 75:2087–2096
Heaton RK, Franklin DR, Ellis RJ, McCutchan JA, Letendre SL, LeBlanc S et al (2011) HIV-associated neurocognitive disorders before and during the era of combination antiretroviral therapy: differences in rates, nature, and predictors. J Neurovirol 17:3–16
Hoffman HS, Ison JR (1980) Reflex modification in the domain of startle: I. Some empirical findings and their implications for how the nervous system processes sensory input. Psychol Rev 87:175–189
Hoffman HS, Searle JL (1965) Acoustic variables in modification of startle reaction in rat. J Comp Physiol Psychol 60:53–58
Ison JR (1982) Temporal acuity in auditory function in the rat: reflex inhibition by brief gaps in noise. J Comp Physiol Psychol 96:945–954
Ison JR, Bowen PG (2000) Scopolamine reduces sensitivity to auditory gaps in the rat, suggesting a cholinergic contribution to temporal acuity. Hear Res 145:169–176
Ison JR, Hammond GR (1971) Modification of startle reflex in rat by changes in auditory and visual environments. J Comp Physiol Psychol 75:435–452
Ison JR, O’Connor K, Bowen GP, Bocirnea A (1991) Temporal resolution of gaps in noise by the rat is lost with functional decortication. Behav Neurosci 105:33–40
Ison JR, Agrawal P, Pak J, Vaughn WJ (1998) Changes in temporal acuity with age and with hearing impairment in the mouse: a study of the acoustic startle reflex and its inhibition by brief decrements in noise level. J Acoust Soc Am 104:1696–1704
Ison JR, Allen PD, Rivoli PJ, Moore JT (2005) The behavioral response of mice to gaps in noise depends on its spectral components and its bandwidth. J Acoust Soc Am 117:3944–3951
Koch M (1999) The neurobiology of startle. Prog Neurobiol 59:107–128
Koch M, Schnitzler HU (1997) The acoustic startle response in rats: circuits mediating evocation, inhibition and potentiation. Behav Brain Res 89:35–49
Koralnik IJ, Beaumanoir A, Hausler R, Kohler A, Safran AB, Delacoux R et al (1990) A controlled-study of early neurologic abnormalities in men with asymptomatic human- immunodeficiency-virus infection. New Engl J Med 323:864–870
Kumar AM, Ownby RL, Waldrop-Valverde D, Fernandez B, Kumar M (2011) Human immunodeficiency virus infection in the CAN and decreased dopamine availability: relationship with neuropsychological performance. J Neurovirol 17:26–40
Leitner DS, Cohen ME (1985) Role of the inferior colliculus in the inhibition of acoustic startle in the rat. Physiol Behav 34:65–70
Leitner DS, Hammond GR, Springer CP, Ingham KM, Mekilo AM, Bodison PR et al (1993) Parameters affecting gap detection in the rat. Percept Psychophys 54:395–405
Letendre SL, Ellis RJ, Ances BM, McCutchan JA (2010) Neurologic complications of HIV disease and their treatment. Top HIV Med 18:45–55
Li L, Yeomans JS (2000) Using intracranial electrical stimulation to study the timing of prepulse inhibition of the startle reflex. Brain Res Protocol 5:67–74
Matas CG, Silva SM, Marcon Bde A, Goncalves IC (2010) Electrophysiological manifestations in adults with HIV/AIDS submitted and not submitted to antiretroviral therapy. Pro Fono 22:107–113
McArthur JC, Steiner J, Sacktor N, Nath A (2010) Human immunodeficiency virus-associated neurocognitive disorders mind the gap. Ann Neurol 67(6):699–714
Minassian A, Henry BL, Woods SP, Vaida F, Grant I, Geyer MA, Perry W (2013) Prepulse inhibition in HIV-associated neurocognitive disorders. J Int Neuropsychol Soc 19:709–717
Moran LM, Aksenov MY, Booze RM, Webb KM, Mactutus CF (2012) Adolescent HIV-1 transgenic rats: evidence for dopaminergic alterations in behavior and neurochemistry revealed by methamphetamine challenge. Curr HIV Res 10:415–424
Moran LM, Booze RM, Mactutus CF (2013a) Time and time again: Temporal processing demands implicate perceptual and gating deficits in the HIV-1 Transgenic rat. J NeuroImmune Pharmacol 8:988–997
Moran LM, Booze RM, Webb KM, Mactutus CF (2013b) Neurobehavioral alterations in HIV-1 transgenic rats: evidence for dopaminergic dysfunction. Exp Neurol 239:139–147
Peng JS, Vigorito M, Liu XQ, Zhous DJ, XW W, Chang SL (2010) The HIV-1 transgenic rat as a model for HIV-1 infected individuals on HAART. J Neuroimmunol 218:94–101
Razani J, Murphy C, Davidson TM, Grant I, McCutchan A (1996) Odor sensitivity is impaired in HIV-positive cognitively impaired patients. Physiol Behav 59:877–881
Reid W, Sadowska M, Denaro F, Rao S, Foulke J, Hayes N et al (2001) An HIV-1 transgenic rat that develops HIV-related pathology and immunologic dysfunction. P Natl Acad Sci USA 98:9271–9276
Roscoe RF Jr, Mactutus CF, Booze RM (2014) HIV-1 transgenic female rat: Synaptodendritic alterations of medium spiny neurons in the nucleus accumbens. J NeuroImmune Pharmacol 9:642–653
Royal W, Zhang L, Guo M, Jones O, Davis H, Bryant JL (2012) Immune activation, viral gene product expression and neurotoxicity in the HIV-1 transgenic rat. J Neuroimmunol 247:16–24
Stevens SS (1970) Neural events and the psychophysical law. Science 170:1043–1050
Sun W, Doolittle L, Flowers E, Zhang C, Wang Q (2014) High doses of salicylate causes prepulse facilitation of onset-gap induced acoustic startle response. Behav Brain Res 258:187–192
UNAIDS (2015) Aids info: indicators. http://aidsinfo.unaids.org/ assessed 22 March 2016
Wang GJ, Change L, Volkow ND, Telang F, Logan J, Ernst T, Fowler JS (2004) Decreased brain dopaminergic transporters in HIV-associated dementia patients. Brain 127:2452–2458
Winer, BJ (1971) Statistical principles in experimental design, 2nd ed. New York
Winston A, Arenas-Pinto A, Stohr W, Fisher M, Orkin CM, Aderogba K et al (2013) Neurocognitive function in HIV infected patients on antiretroviral therapy. PLoS One 8:e61949
Woods SP, Moore DJ, Weber E, Grant I (2009) Cognitive neuropsychology of HIV-associated neurocognitive disorders. Neuropsychol Rev 19:152–168
Zhang J, Forkstam C, Engel JA, Svensson L (2000) Role of dopamine in prepulse inhibition of acoustic startle. Psychopharmacology 149:181–188
Zipursky AR, Gogolishvili D, Rueda S, Brunetta J, Carvalhal A, McCombe JA, Gill MJ, Rachlis A, Rosenes R, Arbess G, Marcotte T, Rourke SB (2013) Evaluation of brief screening tools for neurocognitive impairment in HIV/AIDS: a systematic review of the literature. AIDS 27:2385–2401
Acknowledgments
This work was supported in part by grants from NIH (National Institute on Drug Abuse, DA013137; National Institute of Child Health and Human Development, HD043680; National Institute of Mental Health, MH106392) and the interdisciplinary research training program supported by the University of South Carolina Behavioral-Biomedical Interface Program.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of Interest
The authors declare that they have no conflict of interest.
Rights and permissions
About this article
Cite this article
McLaurin, K.A., Moran, L.M., Li, H. et al. A Gap in Time: Extending our Knowledge of Temporal Processing Deficits in the HIV-1 Transgenic Rat. J Neuroimmune Pharmacol 12, 171–179 (2017). https://doi.org/10.1007/s11481-016-9711-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11481-016-9711-8